Board of trustees

The boards of trustees of the individual Fraunhofer Institutes act as purely advisory bodies to their institute’s management. The members come from academia, industry, and government agencies.

At present, the Fraunhofer ITEM board of trustees is made up of the following members:

(as at May 2024)

Chairman of the board of trustees


Prof. Dr. Tobias Welte †

Director of the Clinic for Pneumology and Infectiology, Hannover Medical School

Prof. Dr. Dieter Jahn (Vice chairman)

Head of the Institute of Microbiology, Technische Universität Braunschweig,
Spokesman of the Braunschweig Integrated Centre of Systems Biology – BRICS



Dr. Karin Conde-Knape

Corporate Vice President Diabetes, Cardio-Renal and Translational Research, Novo Nordisk A/S (Denmark)

Prof. Dr. Susanne Herold

Director of the Clinic for Infectiology and Hospital Hygiene, University Hospital Giessen and Marburg

Prof. Dr. Wolfgang Herr

Full professor and Head of the Department of Internal Medicine III, University Hospital Regensburg

Prof. Dr. Edith M. Hessel

Chief Scientific Officer, Eligo Bioscience (UK)

Prof. Dr. Paul-Georg Germann

Global Head of Chemical and Preclinical Safety (CPS), Biopharma, R&D, Discovery and Development Technologies, Merck Healthcare KGaA

Prof. Dr. Michael P. Manns

President and Member of the Presidium responsible for the Division of Research and Teaching, Hannover Medical School

Ministerialrätin Dr. Evelyn Obele

Head of the Division of Health Research, Medical Technology, German Federal Ministry of Education and Research

Prof. Clive Page, OBE, Ph.D.

School of Cancer and Pharmaceutical Science, King’s College London (UK)

Anna Teschner

Head of the Division of Life Sciences, Humanities, Social Sciences and Academic Libraries, Lower Saxony Ministry of Science and Culture